Search

everythinglearnresearchcommunity

for

Search:↓

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

Laser treatment for hair loss works equally well on different skin types, but more research is needed for very dark skin.

The microbiome may be linked to hair loss and could be a target for new treatments.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

Dermoscopy helps diagnose different scalp conditions by showing unique signs for each disorder.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Dermoscopy is useful for diagnosing different types of hair loss.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

A vibrating anesthetic device significantly reduces pain during mesotherapy for hair loss without complications.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Androgenetic alopecia is the most common cause of hair loss at Sohag University Hospital's hair clinic.

Targeting CXCL12 may help treat hair loss caused by androgens.

Platelet lysate is more effective than activated autologous platelet-rich plasma or saline in improving hair growth after hair restoration surgery.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Some people with chronic hair loss may have thyroid autoimmunity.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

The most common causes of hair loss in a Nigerian hospital were discoid lupus erythematosus of the scalp and alopecia areata, and more research is needed to understand and address these issues.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.